Suggestions
Matt Rosner
Microprism Phoria Treatment: A Competitive Edge for Optometrists
Matt Rosner is a key figure at the NeuroVisual Medicine Institute, where he holds the position of Director of Growth and Development.2 In this role, he is responsible for supporting the institute's global network of trained professionals and overseeing growth strategies for the organization.
Background and Education
Matt Rosner is a graduate of the University of Michigan's Penny W. Stamps School of Art & Design.4 This educational background in art and design has likely contributed to his unique perspective in the field of optometry and neurovisual medicine.
Professional Role
At the NeuroVisual Medicine Institute, Matt Rosner's responsibilities include:
- Leading the global adoption of advanced binocular vision treatment with microprism lenses3
- Supporting optometrists from various backgrounds in implementing neurovisual medicine practices1
- Overseeing growth strategies for the organization
Expertise and Contributions
Matt Rosner has become a prominent figure in the optometry industry, particularly in the area of specialty eye care.4 He is known for his work in promoting and developing the field of neurovisual medicine, which focuses on treating binocular vision dysfunction (BVD) and related conditions.
Rosner's approach involves embracing the mixed reputation of binocular vision in optometry and the broader medical community as a starting point for discussion and education.1 He works to support optometrists in understanding and implementing advanced treatments, such as microprism lenses, which have shown promising results in treating BVD and related symptoms.
Through his role at the NeuroVisual Medicine Institute, Matt Rosner continues to play a significant part in expanding access to neurovisual care and transforming the lives of both optometrists and their patients.